Inventor · disambiguated record
Ulrich Moebius
Also filed as: MOEBIUS ULRICH
8 granted patents·14 pending applications·58 citations·filing 1977–2022
84Inventor score
Top patents by PatentIndex Score
22 records- 0188US7285381B1Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the sameMEDIGENE AG·Filed 2000·Granted Oct 23, 2007·30 cites·28 claims
- 0276US7858662B2Medicament for the treatment of viral skin and tumour diseasesMEDIGENE AG·Filed 2002·Granted Dec 28, 2010·9 cites·25 claims
- 0371US10865250B2Anti-cancer fusion polypeptidePIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Dec 15, 2020·1 cites·8 claims
- 0471US9260521B2Treatment of tumors using specific anti-L1 antibodyDEUTSCHES KREBSFORSCH·Filed 2013·Granted Feb 16, 2016·2 cites·20 claims
- 0567US9770406B2Medicament for the treatment of viral skin and tumour diseasesCHANG YUNIK·Filed 2010·Granted Sep 26, 2017·1 cites·28 claims
- 0659US2021198380A1Anti-cancer fusion polypeptidePIERIS PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 0759US2024350589A1Il-2/il-15rbetagamma agonist combination with antibody-drug conjugates for treating cancerCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 0859US2020054552A1Medicament for the treatment of viral skin and tumour diseasesMEDIGENE AG·Filed 2019·Application pending·0 cites
- 0958US2024294594A1Interleukin-15 based immunocytokinesCYTUNE PHARMA·Filed 2022·Application pending·0 cites
- 1055US2023398185A1Il-2/il-15r-beta-gamma agonist for treating non-melanoma skin cancerCYTUNE PHARMA·Filed 2021·Application pending·0 cites
- 1155US2010105123A2Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the sameMEDIGENE AG·Filed 2007·Application pending·0 cites
- 1255US2024100180A1Tumor-specific claudin 18.2 antibody-drug conjugatesSOTIO BIOTECH A S·Filed 2021·Application pending·0 cites
- 1355US2023390361A1Il-2/il-15r-beta-gamma agonist for treating squamous cell carcinomaCYTUNE PHARMA·Filed 2021·Application pending·0 cites
- 1452US10434059B2Medicament for the treatment of viral skin and tumour diseasesFOUGERA PHARMACEUTICALS INC·Filed 2017·Granted Oct 8, 2019·0 cites·26 claims
- 1551US2024034783A1Tumor-specific claudin 18.2 antibodiesSOTIO BIOTECH A S·Filed 2020·Application pending·0 cites
- 1651US2023030674A1Humanized cldn18.2 antibodiesSOTIO BIOTECH A S·Filed 2020·Application pending·0 cites
- 1748US8580258B2Treatment of tumors using specific anti-L1 antibodyKELM DANIELA·Filed 2012·Granted Nov 12, 2013·0 cites·22 claims
- 1847US2022241375A1Il-2/il-15r beta gamma agonist dosing regimens for treating cancer or infectious diseasesCYTUNE PHARMA·Filed 2020·Application pending·0 cites
- 1947US2005025789A1Allogenic vaccine that contains a costimulatory polypeptide-expresing tumor cellFiled 2002·Application pending·0 cites
- 2045US4132187AManual device for indicating scoresMOEBIUS ULRICH·Filed 1977·Granted Jan 2, 1979·15 cites·9 claims
- 2135US2004087026A1Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereofFiled 2001·Application pending·0 cites
- 2234US2004053410A1Method for introducing a nucleic acid into a cell (transfection) by means of calcium phosphate and transfected cellFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrich Moebius files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →